BrainStorm Cell Therapeutics
BCLI
#10451
Rank
S$12.2 M
Marketcap
S$1.11
Share price
-9.47%
Change (1 day)
-33.20%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -S$14.3 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$14.96 Million, an increase over its 2023 earnings that were of -S$22.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$14.3 Million-4.41%
2024 -S$14.96 Million-32.39%
2023 -S$22.12 Million-29.18%
2022 -S$31.24 Million-0.74%
2021 -S$31.47 Million-23.12%
2020 -S$40.93 Million36.8%
2019 -S$29.92 Million66.71%
2018 -S$17.95 Million181.66%
2017 -S$6.38 Million-0.6%
2016 -S$6.41 Million-41.31%
2015 -S$10.92 Million-8.22%
2014 -S$11.9 Million89.74%
2013 -S$6.28 Million42.27%
2012 -S$4.41 Million-12.45%
2011 -S$5.04 Million63.04%
2010 -S$3.09 Million35.52%
2009 -S$2.28 Million-48.99%
2008 -S$4.47 Million-44.39%
2007 -S$8.04 Million
2005 -S$4.16 Million-91.44%
2004 -S$48.61 Million94007.62%
2003 -S$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
S$2.00 B-14,450.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.60 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-S$1.02 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.01 Billion 7,137.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.58 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-S$0.33 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA